Clinical trial
Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral…
NCT00437684 · IRCCS San Raffaele, Other · Unknown status
Key facts
| NCT number | NCT00437684 |
|---|---|
| Title | Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Patients Starting Treatment With Anti-Hepatitis C Virus (HCV) Therapy |
| Official title | A Pilot, Open Label, Multicenter, Randomized Clinical Trial on Lopinavir/Ritonavir-Monotherapy vs Lopinavir/Ritonavir Plus Selected Nucs, in HIV/HCV Coinfected Patients With Chronic Hepatitis C or Compensated Cirrhosis, Starting Treatment With Ribavirin and Pegylated Interferon |
| Lead sponsor | IRCCS San Raffaele, Other |
| Collaborators | Abbott Industry Hoffmann-La Roche |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | HIV Infections, Hepatitis C |
| Intervention type | Drug |
| Interventions | LPV/r, PEG-IFNa 2a, Ribavirin, NUCS |
| Enrollment | 50 |
| Start date | Feb 1, 2007 |
| Primary completion | Jul 1, 2010 |
| Completion | Dec 1, 2010 |
| First posted | Feb 21, 2007 |
| Last update posted | Feb 6, 2009 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: